Featured Research

from universities, journals, and other organizations

Drug Resistance Found To Vary By Ethnicity

Date:
March 28, 2001
Source:
Washington University School Of Medicine
Summary:
A genetic mutation affecting resistance to chemotherapy occurs more frequently in some ethnic groups than in others according to a new study. Researchers found that African and African American populations included more individuals with the drug-resistant gene than Caucasian or Asian populations.

New Orleans, March 25, 2001 -- A genetic mutation affecting resistance to chemotherapy occurs more frequently in some ethnic groups than in others according to a new study.

Researchers found that African and African American populations included more individuals with the drug-resistant gene than Caucasian or Asian populations. This might help explain why some people of African descent respond poorly to chemotherapy. The research will be presented March 25 at the annual meeting of the American Association for Cancer Research in New Orleans.

"We now know that the genetic influence on drug resistance is not the same throughout the whole population," says Howard L. McLeod, Pharm.D., associate professor of medicine, of pharmacology and molecular biology and of genetics at Washington University School of Medicine in St. Louis. "Because of this work, we can try to solve the problem."

McLeod, who led the international team of researchers from his previous position at the University of Aberdeen in the United Kingdom, specializes in pharmacogenetics, an emerging research field. Margaret-Mary Ameyaw, M.D., Ph.D., of the University of Aberdeen is the study’s first author and will join the Washington University faculty later this year.

The mutation studied by McLeod and his colleagues changes production of a protein called P-glycoprotein, or PGP, a molecular pump that rids cells of drugs. When working correctly, PGP pumps chemotherapeutic drugs out of tumors, allowing the tumor cells to survive. This response is known as drug resistance. The genetic mutation means the PGP pump stops working, allowing drugs to enter and kill tumor cells.

PGP also rids cells of many other medications, such as HIV protease inhibitors and drugs used to control high blood pressure and prevent failure of kidney transplants.

Working with collaborators in five countries, McLeod and his colleagues did DNA tests on blood samples from 1,280 people from 10 ethnic populations. The researchers studied Ghanaian, African American, southwest Asian, British Caucasian and Saudi populations as well as people native to Portugal, China, Kenya, the Sudan and the Philippines.

They found that some populations were significantly more likely than others to contain the mutation.

The groups of African descent – Ghanaian, Kenyan, African American and Sudanese – had the mutation significantly less frequently than the Caucasian/Asian populations.

Because lack of the mutation is associated with higher expression of PGP and thus higher drug resistance, these findings mean that physicians may soon have the necessary tools for individualizing therapy, especially for people of African heritage. Extreme interventions would not be necessary because an existing medication that chemically inhibits the PGP protein could be given to people found to overexpress PGP.

Many factors affect survival rates among cancer patients. "While I believe that the biggest reason some African-American cancer patients do not do as well as Caucasian patients is because of their access to care, this finding suggests that there is a little bit more to it," McLeod says. "Knowing this, we should be able to help decrease the variability in the way people are treated."

Previous studies have shown that there are ethnic and racial differences in the ability to make several proteins important for successful drug therapy. "So it’s always been an interest of mine not to confine my investigations to 18- to 35-year-old Caucasian males, which is where most drugs are studied, but to try to look at males and females of different ethnic groups," McLeod says.

Ameyaw M-M, Regateiro F, Li T, Liu X, Tariq M, Mobarek A, Thornton N, Folayan GO, Githang’a J, Indalo A, Ofori-Adjei D, Price-Evans DA, McLeod HL. MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Presented at American Association for Cancer Research Annual Meeting March 24, 2001.

Funding from the Wellcome Trust supported this research.

The full-time and volunteer faculty of Washington University School of Medicine are the physicians and surgeons of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Drug Resistance Found To Vary By Ethnicity." ScienceDaily. ScienceDaily, 28 March 2001. <www.sciencedaily.com/releases/2001/03/010327080620.htm>.
Washington University School Of Medicine. (2001, March 28). Drug Resistance Found To Vary By Ethnicity. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2001/03/010327080620.htm
Washington University School Of Medicine. "Drug Resistance Found To Vary By Ethnicity." ScienceDaily. www.sciencedaily.com/releases/2001/03/010327080620.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins